Health care stocks rose Thursday afternoon, with the NYSE Health Care Index adding 1.4% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.3%.
The iShares Biotechnology ETF (IBB) advanced 1.4%.
In corporate news, Alterity Therapeutics (ATHE) shares surged past 51% after the company said its ATH434 lead candidate demonstrated 48% slowing of clinical progression in a phase 2 trial in people with early-stage multiple system atrophy.
Tectonic Therapeutic (TECX) shares soared 94% after it said a phase 1b trial showed that TX45 improved left ventricular function and pulmonary hemodynamics.
Cigna (CI) shares fell 8.1% after it reported a decline in Q4 adjusted earnings, which also missed market expectations.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。